Mettler-Toledo International, Inc. (NYSE:MTD) Receives $1,336.50 Consensus Target Price from Brokerages

Mettler-Toledo International, Inc. (NYSE:MTD) has been assigned an average recommendation of “Hold” from the twelve research firms that are presently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $1,336.50.

Several research firms have recently commented on MTD. Citigroup upped their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Evercore ISI upped their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Robert W. Baird upped their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. Finally, Bank of America upped their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd.

Insider Buying and Selling

In related news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares of the company’s stock, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider directly owned 94 shares of the company’s stock, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Signaturefd LLC lifted its holdings in shares of Mettler-Toledo International by 2.5% in the 3rd quarter. Signaturefd LLC now owns 407 shares of the medical instruments supplier’s stock valued at $500,000 after acquiring an additional 10 shares during the last quarter. SJS Investment Consulting Inc. lifted its holdings in shares of Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares during the last quarter. Generali Asset Management SPA SGR lifted its holdings in shares of Mettler-Toledo International by 4.4% in the 3rd quarter. Generali Asset Management SPA SGR now owns 1,515 shares of the medical instruments supplier’s stock valued at $1,860,000 after acquiring an additional 64 shares during the last quarter. Salomon & Ludwin LLC bought a new position in shares of Mettler-Toledo International in the 3rd quarter valued at about $43,000. Finally, Mather Group LLC. bought a new position in shares of Mettler-Toledo International in the 3rd quarter valued at about $140,000. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,386.33 on Friday. The stock’s 50 day simple moving average is $1,291.25 and its two-hundred day simple moving average is $1,199.43. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,438.46. The stock has a market cap of $28.56 billion, a price-to-earnings ratio of 35.11, a PEG ratio of 4.07 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. During the same period in the previous year, the firm posted $9.65 EPS. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.